Tomas Olsson

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Paul O’Connor, Jerry S. Wolinsky, Christian Confavreux et al. · New England Journal of Medicine · 2011 · 965 citations · Full text

Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis

Barbara Kornek, Maria K. Storch, Robert Weissert et al. · American Journal Of Pathology · 2000 · 908 citations · Full text

Autoimmune Disease, Neurological Disorder, Lupus +10

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

Xavier Montalbán, Ralf Gold, Alan J. Thompson et al. · Multiple Sclerosis Journal · 2018 · 664 citations · Full text

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O’Connor, Mark Freedman et al. · The Lancet Neurology · 2014 · 566 citations

Oral Teriflunomide, Neurological Disorder, Medicine +6